12/15/2017 | CVLM | Omnicare calls 3.25% convertible debentures due 2035
|
10/21/2015 | CVLM | CVS Health wraps tender offer for Omnicare’s 4.75% notes, 5% notes
|
10/6/2015 | CVLM | CVS Health gets consents to amend Omnicare’s 4.75% notes, 5% notes
|
9/16/2015 | CV | Omnicare: Interest to accrue on series A, B trust Piers for quarter
|
9/4/2015 | BKCVHYIG | S&P upgrades Omnicare, debt
|
9/3/2015 | CVLM | Omnicare to redeem all $62.29 million 3.5% convertible notes due 2044
|
8/18/2015 | CV | Omnicare adjusts terms of convertibles following acquisition by CVS
|
5/21/2015 | CV | Market Commentary: Cemex bonds mixed on exchange deal; Omnicare slips on swap on buyout news; Vipshop adds
|
5/21/2015 | BKCVHYPF | Moody’s might lift Omnicare
|
5/21/2015 | BKCVHYPF | S&P might lift Omnicare
|
5/21/2015 | CV | Market Commentary: Morning Commentary: Cemex active after exchange; Omnicare busy on buyout news; Trina shares pop
|
4/27/2015 | CV | Market Commentary: Tesla adds on swap as shares pull higher; Omnicare flat; Echo Global Logistics launches
|
3/27/2015 | CV | Omnicare declares contingent cash interest, adjusts conversion rate
|
1/9/2015 | CV | Omnicare declares contingent cash interest, adjusts conversion rate
|
11/24/2014 | BKCVHYPF | Moody’s corrects Omnicare rating
|
11/11/2014 | CV | Market Commentary: Existing Isis bonds, shares up; planned Isis looks slightly rich; Ascent Capital shares drop
|
11/11/2014 | CV | Omnicare adjusts conversion rate for 3.75% convertibles due 2042
|
11/10/2014 | BKCVDDEMIGPV | Market Commentary: SuperValu drive-by, Greystar, restructured Canbriam price; market quiet ahead of holiday
|
11/10/2014 | CVLM | Omnicare calls 3.75% convertibles due 2042 for redemption on Dec. 10
|
11/7/2014 | BKCVDDEMIGPV | Market Commentary: Upsized Sealed Air drive-by, Blue Racer, Essar price to close $8 billion week; new Omnicare higher
|
11/6/2014 | BKCVDDEMIGPV | Market Commentary: Omnicare, Abengoa price; Avis, Truven drive by; new DISH busy; funds jump $2.44 billion
|
11/6/2014 | CVHYLM | Omnicare to redeem $400 million 7¾% notes, might redeem convertibles
|
11/5/2014 | BKCVHYPF | Moody’s cuts Omnicare loans, notes; rates notes Ba2
|
11/5/2014 | BKCVHY | S&P rates Omnicare notes BBB-
|
11/3/2014 | CV | Market Commentary: American Realty bonds take another leg lower; Omnicare higher; Owens-Illinois sets tender
|
10/31/2014 | CVLM | Omnicare to swap out $241.5 million 3.25% convertibles due 2035
|
10/29/2014 | CV | Omnicare’s series A, B trust Piers accrue contingent interest
|
7/23/2014 | BKBWCVHYLM | Omnicare ends second quarter with $315 million cash, record cash flows
|
7/23/2014 | CVLM | Omnicare repurchases $52 million 3.75% convertibles in second quarter
|
4/23/2014 | BKCVHY | Omnicare ends first-quarter 2014 with $347 million cash on hand
|
4/8/2014 | CV | Omnicare adjusts conversion rate of 3.75% convertibles due 2025
|
3/27/2014 | BKCVHY | Moody's: Omnicare view to negative
|
3/4/2014 | CV | Market Commentary: Midday Commentary: Tesla regains par; Omnicare holds just under par; Cowen convertibles on tap
|
1/10/2014 | CV | Omnicare ups convertibles' conversion rates, raises Piers interest
|
10/23/2013 | BKCVHY | Omnicare ends Q3 with $506 million cash, retires $180 million of notes for new debt
|
10/18/2013 | CV | Omnicare's series A, B trust PIERS to accrue contingent interest
|
8/27/2013 | BKCVHY | S&P rates Omnicare convertibles BB
|
8/26/2013 | BKCVHY | Moody's rates Omnicare convertibles Ba3
|
8/23/2013 | CV | Market Commentary: Omnicare's new exchanged notes dominate trade; Tesla contracts on hedge; Dendreon slips
|
8/23/2013 | CVLM | Omnicare to swap out some 3.75% convertibles due 2044 for new notes
|
7/24/2013 | CV | Market Commentary: New American Realty trades around reoffer price; Radian flat to slightly higher on swap
|
5/16/2013 | BKCVHY | Omnicare allocates excess cash to increase shareholder value, says CEO
|
1/22/2013 | CV | Omnicare adjusts conversion rate of 3.25% convertibles due 2035
|
1/3/2013 | BKCVHY | Omnicare considers acquisitions, will hold leverage steady, says CEO
|
9/25/2012 | BKCVHY | Moody's rates Omnicare loans Baa3
|
9/14/2012 | BKCVHY | S&P rates Omnicare loan BBB-
|
8/31/2012 | CV | Market Commentary: Convertibles mostly flat for week; some see mixed performance for month, but indices gain
|
6/11/2012 | CV | Market Commentary: Alpha Natural gains on hedge despite coal share slump; Navistar up on hedge; Omnicare in line
|
4/2/2012 | CV | Market Commentary: Convertibles flat to weaker: Gilead weaker, unchanged on hedge; James River down on hedge
|
3/30/2012 | BKCVHY | Moody's assigns Ba3 to Omnicare convertible notes
|
3/30/2012 | CV | Market Commentary: Sino-Forest weaker on bankruptcy filing; United Rentals moves higher; Amylin extends gains
|
3/29/2012 | CV | Market Commentary: Omnicare active, holders make 5 points on exchange; Illumina adds on hedge; Amylin gains
|
3/29/2012 | CVHY | S&P: Omnicare convertibles BB
|
3/29/2012 | CVLM | Omnicare to exchange $256.95 million 3.75% convertibles for new notes
|
3/16/2012 | CVHYIG | Moody's confirms Omnicare
|
1/30/2012 | CVHY | Moody's: Omnicare unaffected
|
1/30/2012 | CV | Market Commentary: Amylin active; Theravance better bid; MF Global 'comes in'; RadioShack warns on earnings
|
10/25/2011 | BKCVHY | Omnicare reports 'robust' cash flows from operations of $167.1 million
|
10/24/2011 | CV | Market Commentary: Convertibles rise on light volume; Radian up; hedged players lose on RightNow's Oracle offer
|
10/21/2011 | CV | Market Commentary: SanDisk moves up on positive earnings; Old Nuance opens up; Investment-grade names active
|
9/15/2011 | BKCVHYPF | S&P: Omnicare unchanged
|
9/15/2011 | BKCVHYPF | Moody's: Omnicare notes Ba3
|
8/23/2011 | BKCVHYPF | Moody's reviews Omnicare
|
8/23/2011 | CV | Market Commentary: Omnicare down on acquisition plan; James River lower; Kodak improves with lower shares
|
8/4/2011 | BKCVHY | S&P rates Omnicare loan BBB-
|
8/4/2011 | BKCVHYPF | Moody's: Omnicare loan Baa3
|
3/16/2011 | BKCVHY | Omnicare likely to continue chipping away at 2015 maturities, CFO says
|
2/24/2011 | CV | Market Commentary: Salix lower on hedge on drug setback; Newmont Mining drops in line after earnings released
|
1/5/2011 | CV | Market Commentary: ADM, Beckman Coulter active in dealer-to-dealer trade; Newmont Mining slips; WebMD on tap
|
12/16/2010 | CV | Market Commentary: Swift edges over par on debut; Prospect Capital bags overnight deal; Omnicare trades lower
|
12/16/2010 | CVLM | Omnicare accepts $525 million of 3.25% convertibles in tender offer
|
12/10/2010 | BKCVHY | S&P rates Omnicare notes BB
|
12/3/2010 | CV | Market Commentary: Clearwire slumps on debut as hedge players steer clear; Vertex below par; Cameron rises
|
12/2/2010 | CV | New Issue: Omnicare prices $500 million 15-year convertibles at 3.75%, up 23.5%
|
12/2/2010 | CV | Market Commentary: New Omnicare does well on debut; Ixia pulls up in the end; Clearwire quiet in the gray
|
12/1/2010 | CV | Market Commentary: New China Medical adds; existing China Medical bonds active; Omnicare, Ixia paper on tap
|
12/1/2010 | CVHY | Moody's assigns Ba3 to Omnicare convertibles
|
11/30/2010 | CV | Omnicare plans to price $500 million 15-year convertibles to yield 3.5%-4%, up 20%-25%
|
11/30/2010 | CV | Market Commentary: China Medical quiet in the gray; Swift plans $300 million mandatory; Omnicare launches
|
11/19/2010 | CV | Market Commentary: New GM mandatory slips below par; Salesforce gains dollar neutral; new RightNow improves
|
11/18/2010 | CV | Market Commentary: New GM mandatory trades higher; new PDC adds; Omnicare up on tender; Hologic exchanges
|
11/17/2010 | CVLM | Omnicare begins tender for $525 million 3.25% convertibles due 2035
|
10/27/2010 | CV | Market Commentary: Digital River gains on debut; Equinix higher, in line; Energy XXI, Green Plains on tap
|
8/9/2010 | BKCVHY | Moody's cuts Omnicare view to negative
|
8/9/2010 | CV | Market Commentary: Convertibles quiet; Beckman Coulter recoups a little; King Pharmaceuticals down a point
|
8/6/2010 | CV | Market Commentary: Convertibles quiet: Transocean, Omnicare flat; Trico extends weakness; ADM paper improves
|
8/5/2010 | CV | Market Commentary: Transocean extends gains; Omnicare down after earnings; NetApp active; Trico Marine sinks
|
8/3/2010 | CV | Market Commentary: Teleflex adds slightly in gray market, prices; MGM strengthens; PHH gains after debt issue
|
6/14/2010 | CV | Market Commentary: Transocean fluctuates; Microsoft flat on hedged basis; Chesapeake Energy a little weaker
|
5/21/2010 | CV | Market Commentary: Convertibles unsteady; Amgen, Omnicare lower; Cemex firms; Symmetricom buying 3.25% notes
|
5/10/2010 | CVHYPF | Omnicare files automatic shelf covering preferreds, debt and stock
|
5/6/2010 | BKBWCVHY | Omnicare boasts strong cash flow, debt reduction in first quarter
|
5/5/2010 | BKCVHY | Moody raises Omnicare
|
5/5/2010 | BKCVHY | S&P: Omnicare outlook stable
|
4/5/2010 | CV | Market Commentary: Convertibles mostly quiet, but Exterran, Hologic edge up; Omnicare strong; Telvent to price
|
3/23/2010 | BKBWCVHY | Omnicare repays more term loan A debt in 2010; balance now $50 million
|
3/19/2010 | CV | Market Commentary: Hartford eases with stock; Lifepoint, other health care names steady to stronger; Rovi slips
|
2/17/2010 | CV | Market Commentary: Omnicare weaker on hedged basis; YRC better on hedge; Avis convertibles indicated higher
|
11/11/2009 | CV | Market Commentary: United Rentals trades above par; TeleCommunication higher; buyers boost Medtronic, Omnicare
|
10/23/2009 | CV | Market Commentary: Navistar, Dole Food notes slip on their debuts; GMX adds but mostly quiet; Jefferies flat
|
8/14/2009 | CV | Market Commentary: NCI jumps on exchange offer; Regions Financial adds; Omnicare a little weaker; CACI slips
|
7/30/2009 | CV | Market Commentary: New Sybase, THQ up in trading; Arris adds with stock down; Symantec, Omnicare slip on results
|
4/22/2009 | CV | Market Commentary: Watson, OSI add on buyout rumors; Alexandria up; Ford jumps, GM mixed; Old Republic to price
|
4/20/2009 | CV | Market Commentary: Financials get knocked down; Omnicare remains active, holds gains; SBA prices upsized deal
|
4/17/2009 | CV | Market Commentary: Citigroup improves; Omnicare adds on buyout rumor; GM recoups for the week; Kemet gets a look
|
4/8/2009 | BKBWCVHY | Omnicare eyes debt reduction, repays $75 million of loan in March
|
2/27/2009 | CV | Market Commentary: Financials lifted by Citi exchange offer; Citi preferreds jump; health care under pressure
|
2/26/2009 | BKBWCVHY | Omnicare repays $89.1 million of debt in 2008
|
11/7/2008 | CV | Market Commentary: GM, Ford weaker after reported losses, cash burn; Sprint Nextel extends gains; Wyeth firm
|
5/8/2008 | BKCVHY | Omnicare repays $50 million of debt in first quarter, increases full-year cash flow guidance
|
5/8/2008 | CV | Market Commentary: WCI drops on liquidity concerns; financials steady on weaker stocks; Omnicare adds; TTM to price
|
4/16/2008 | BKCVHY | Moody's lowers Omnicare
|
12/20/2007 | BKCVHY | S&P cuts Omnicare
|
11/27/2007 | BKCVHY | Omnicare may use record cash flow to fund acquisitions, balance sheet improvements
|
11/7/2007 | CV | Market Commentary: Washington Mutual, Countrywide, Fannie Mae down; General Motors drives to loss; Omnicare probes depths
|
9/28/2007 | CV | Market Commentary: Omnicare up on takeover rumors; GM up as contract details emerge; hopes rise for fourth quarter
|
8/30/2007 | CV | Market Commentary: Thornburg launches preferreds; Schering-Plough, other biotechs active; Sirius starts truckin'
|
7/5/2007 | CV | Market Commentary: Hilton catches eyes; Huntsman hunted; Foreign convertibles dominate new issues activity
|
6/26/2007 | BKCVHYSS | Omnicare seeking acquisitions as part of strategy to increase shareholder value
|
6/18/2007 | BKCVHY | S&P cuts Omnicare
|
11/15/2006 | BKCVHY | Moody's downgrades Omnicare
|
10/31/2006 | CV | Market Commentary: Omnicare improves hedged on results; Core Labs offered higher in gray; Medical Properties plans deal
|
9/29/2006 | CV | Moody's ups Omnicare convertibles to B1
|
9/20/2006 | BKCVHY | S&P lowers Omnicare outlook to negative
|
8/24/2006 | BKCVHY | Moody's cuts Omnicare view to negative
|
7/27/2006 | CV | Market Commentary: Omnicare withstands profit cut; Symantec rises with results; XM unmoved by loss; Weingarten plans deal
|
6/15/2006 | CV | Market Commentary: Omnicare, Encysive climb on positive regulatory news; SanDisk gains on upgrade; Synaptics up in line
|
5/25/2006 | CV | Market Commentary: Encysive gains outright on FDA submission; Omnicare, XM Satellite better on hedge amid stock declines
|
2/2/2006 | CV | Market Commentary: ImClone steady despite lack of Bristol-Myers interest; Teva under pressure; Omnicare edges lower
|
1/31/2006 | CV | Market Commentary: Earnings send Sepracor higher, but UnumProvident, Goodyear lower; Huntsman adds on takeout talk
|
1/30/2006 | CV | Market Commentary: Omnicare converts plunge on raid news; new DRS issue slows down; GMAC bids lift GM
|
12/23/2005 | CV | Market Commentary: Albertson's trades lower in active trade; Wyeth, Omnicare gain; GM sees light buying
|
12/15/2005 | CV | Omnicare underwriters exercise greenshoe, raising convertibles to $977.5 million
|
12/13/2005 | CV | New Issue: Omnicare upsized $850 million 30-year convertibles yield 3.25%, up 33.5%
|
12/13/2005 | CV | Market Commentary: Omnicare edges higher; Intel, Ceradyne on deck; price talk emerges on Entergy mandatories
|
12/12/2005 | CV | Market Commentary: Intel launches $1.4 billion convertible offering; Omnicare to price; MedImmune edges up
|
12/12/2005 | CV | Omnicare prices upsized $850 million convertibles to yield 3.25%, up 33.5%
|
12/9/2005 | CV | Market Commentary: Cephalon, Teva gain on patent settlement; eyes turn toward Omnicare; Alltel mostly quiet
|
12/8/2005 | CVHY | Omnicare files debt shelf
|
12/5/2005 | CV | Omnicare $750 million 30-year convertibles talked to yield 3.125%-3.625%, up 32.5%-37.5%
|
12/5/2005 | CV | Market Commentary: U.S. Bancorp brings $2 billion; Kansas City Southern, St. Jude, Omnicare also launch; Calpine down
|
8/17/2005 | CVHY | Omnicare files $2.8 billion shelf
|
8/4/2005 | CV | Market Commentary: Affordable Residential issue rises; Human Genome loses ground; LifePoint prices after the close
|
5/20/2005 | BKCV | Moody's rates Omnicare Piers Ba3, cuts view to negative
|
3/8/2005 | CV | Omnicare exchanges 96.7% of 4% Piers
|
2/8/2005 | CV | S&P rates Omnicare Piers BB
|
2/7/2005 | CV | Omnicare starts exchange for 4% Piers
|
5/24/2004 | BKCVHY | S&P may cut NeighborCare, Omnicare
|
1/1/2004 | BKCVHY | Moody's assigns Omnicare SGL-1 rating
|
9/24/2003 | CV | Merrill recommends Omnicare preferred for yield, exposure to solid credit
|
6/13/2003 | CV | Comverse buys back $165.1 million convertibles
|
6/10/2003 | CV | Omnicare upsized $300 million convertible trust preferreds yield 4.0%, up 40%
|
6/9/2003 | CV | Market Commentary: Week begins slowly with a thin market; Omnicare prices, three more small deals emerge
|
6/6/2003 | CV | Market Commentary: Convertibles see record week with 16 deals totaling $4.47 billion; Cephalon, Continental climb
|
6/4/2003 | CV | Omnicare $250 million convertible Piers talked to yield 4.0-4.5%, up 30-35%
|
6/4/2003 | CV | Moody's rates new Omnicare convert Ba3
|
6/4/2003 | CV | Market Commentary: Airline paper flies; energy issues power up after Mirant scare; Schlumberger resold under par
|
2/12/2003 | CV | S&P rates Teekay convert BB-
|
1/15/2003 | CV | Fitch rates State Street convertible AA-
|
12/17/2002 | CV | Moody's confirms Northrop
|
12/16/2002 | CV | S&P rates Lamar unit
|
12/12/2002 | CV | Bear Stearns recommends Omnicare convert on prospect of NCS merger
|
10/31/2002 | CV | Market Commentary: Firm tone on rising confidence; Allergan prices $450 million, Lucent, EDS active
|
8/13/2002 | CV | Moody's rates Service Corp. notes B1
|
8/12/2002 | CV | Fitch cuts PerkinElmer to junk
|